Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseReduction of mitoferrin results in abnormal development and extended lifespan in Caenorhabditis elegansPharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticlesBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseCell delivery of therapeutic nanoparticlesNanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!Advances in iron chelation: an update.Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinionThe oral iron chelator deferiprone protects against iron overload-induced retinal degenerationRole of metal dyshomeostasis in Alzheimer's disease.Neuronal and vascular oxidative stress in Alzheimer's disease.Impaired iron status in aging researchSystemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retinaThe emerging role of iron dyshomeostasis in the mitochondrial decay of aging.Antioxidant approaches for the treatment of Alzheimer's disease.Novel drug targets based on metallobiology of Alzheimer's disease.TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo.Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation.Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.Increased iron and oxidative stress are separately related to cognitive decline in elderly.Exploring geometric properties of gold nanoparticles using TEM images to explain their chaperone like activity for citrate synthase.Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels.Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.Biogenic synthesis of gold nanoparticles from Terminalia arjuna bark extract: assessment of safety aspects and neuroprotective potential via antioxidant, anticholinesterase, and antiamyloidogenic effects.Inhibition of matrix metalloproteinases and toxicity of gold and platinum nanoparticles in L929 fibroblast cells.Gold Nanoparticles Inhibit Matrix Metalloproteases without Cytotoxicity.Matrix metalloproteases inhibition and biocompatibility of gold and platinum nanoparticles.Nanotechnology Applications in Neuroscience: Advances, Opportunities and Challenges
P2860
Q24289511-82C28E86-3464-4A54-B750-B00A6939FA6BQ27021700-1B56C1DA-C85F-44C6-81A2-D3BB0D49B054Q27310363-A8F9A116-8051-45AA-85F4-84D092C0A907Q28084443-69FFCEBD-AF3E-4EDC-8B8C-DE456DDEE31CQ28259585-860D8726-3087-471E-9EE9-8AB2F33AAC8AQ28385606-851F76C0-EDA0-4F62-8C94-A5EA24C4A231Q33957213-9D22186E-7A27-41D8-9E89-26E2CC6B412DQ34174307-9426ACEC-5934-496B-8761-114EBD0F4143Q34186434-EEBDF019-564D-42DA-BC23-30A6ED4DFF36Q34281402-AF74265C-B884-4470-9F17-807139CCB8EDQ35051952-E7112D38-AB65-4D2D-8E3B-DD87D966BAE7Q35687039-2A011BDB-32E7-46F5-8B5C-4CBB632830FEQ35795910-0A777DB7-126C-4FB3-82E6-DF9E5070EC90Q36050418-B07E6E5B-FF3A-496F-A82E-8508FAB3F4FBQ37740429-97FCEA1E-62DD-486F-83A1-39915D112912Q37768449-C0BD68BD-3724-4E2F-A82A-4B7722B3174AQ37799838-6562C320-56D5-4035-9903-98F7DBD19E06Q38797668-F79279EF-6F5D-4FF3-A49F-8012E8CF3181Q39398994-7306D156-2982-43D4-80B9-372C8D9C0B55Q39672604-56412CA3-3D27-426F-B580-6B32C4380FF9Q39766604-B1C68656-DEA0-45B0-995C-2D0B139A0568Q41160836-B288231D-8B17-462B-9FDC-B2612F3C51C8Q42055242-A1214CE1-7640-409E-987E-37B3E4B05626Q47914237-495A84E2-DECD-4367-BA57-2467022A3102Q50195753-207B630D-3EC7-43BC-9C9D-FEE7E2737F0BQ51585312-0B090A5F-A906-46B7-B289-1A4447352517Q52939052-3B1795DE-E17E-4201-A0F1-BA30045E40F5Q53376357-9B2A8BA0-F69A-4954-AE37-12A05E211AFAQ57820305-F99EB851-95E7-42D7-883B-C1BADCE1DA81
P2860
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@ast
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@en
type
label
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@ast
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@en
prefLabel
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@ast
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@en
P2860
P921
P1476
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.
@en
P2093
P2860
P304
P356
10.1007/978-1-60327-029-8_8
P407
P577
2010-01-01T00:00:00Z